Skip to main content

CITADEL ADVISORS LLC

Position in BIOA — BioAge Labs, Inc.

CIK 1423053 MIAMI, FL

Position in BIOA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$3,050,083 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
5 quarters on record

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Derivatives in BIOA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$300,828
PutShares
17,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $928,363,116 across 59 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in BIOA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $300,828 17,200
2025-12-31 $3,050,083 230,543
2025-09-30 $670,690 114,063
2025-09-30 $65,268 11,100
2025-09-30 $137,004 23,300
2025-06-30 $452,668 109,605
2025-06-30 $100,359 24,300
2024-09-30 $4,445,334 213,718